130 related articles for article (PubMed ID: 23398293)
1. Pustular eruption induced by sorafenib in a case of psoriasis vulgaris.
Maki N; Komine M; Takatsuka Y; Maekawa T; Murata S; Ohtsuki M
J Dermatol; 2013 Apr; 40(4):299-300. PubMed ID: 23398293
[No Abstract] [Full Text] [Related]
2. Sneddon-Wilkinson disease induced by sorafenib in a patient with advanced hepatocellular carcinoma.
Tajiri K; Nakajima T; Kawai K; Minemura M; Sugiyama T
Intern Med; 2015; 54(6):597-600. PubMed ID: 25786448
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib-induced severe urticaria in a patient with hepatocellular cancer.
Musri FY; Mutlu H; Kıvrak Salim D; Karakurt Eryılmaz M; Ünal B; Tural D; Şenol Coşkun H
J Oncol Pharm Pract; 2016 Apr; 22(2):350-3. PubMed ID: 25567520
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib-induced annular pustular psoriasis (Milian-Katchoura type).
Du-Thanh A; Girard C; Pageaux GP; Guillot B; Dereure O
Eur J Dermatol; 2013; 23(6):900-1. PubMed ID: 24184416
[No Abstract] [Full Text] [Related]
5. Professor Shukui Qin: patient reported outcomes in study of axitinib or sorafenib in Asian patients with metastatic renal cell carcinoma.
Qin S; Zhang S
Chin Clin Oncol; 2015 Mar; 4(1):15. PubMed ID: 25841722
[No Abstract] [Full Text] [Related]
6. Sorafenib: osteonecrosis of the jaw.
Prescrire Int; 2015 Nov; 24(165):269. PubMed ID: 26688904
[No Abstract] [Full Text] [Related]
7. Pancreatic atrophy--a new late toxic effect of sorafenib.
Hescot S; Vignaux O; Goldwasser F
N Engl J Med; 2013 Oct; 369(15):1475-6. PubMed ID: 24106956
[No Abstract] [Full Text] [Related]
8. Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib.
Pichler M; Carriere C; Mazzoleni G; Kluge R; Eisendle K
Clin Exp Dermatol; 2014 Mar; 39(2):232-3. PubMed ID: 24330088
[No Abstract] [Full Text] [Related]
9. Learning from 7 Years of Experience with Sorafenib in Advanced HCC: Sorafenib Better than Sorafenib?
Faivre S; de Gramont A; Raymond E
Target Oncol; 2016 Aug; 11(4):565-7. PubMed ID: 26996978
[No Abstract] [Full Text] [Related]
10. Sorafenib induced eruptive melanocytic lesions.
Uhlenhake EE; Watson AC; Aronson P
Dermatol Online J; 2013 May; 19(5):18184. PubMed ID: 24011281
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical exacerbation of chronic plaque psoriasis by sorafenib.
Yiu ZZ; Ali FR; Griffiths CE
Clin Exp Dermatol; 2016 Jun; 41(4):407-9. PubMed ID: 26667599
[TBL] [Abstract][Full Text] [Related]
12. Hand-foot-skin reaction related to use of the multikinase inhibitor sorafenib and hard orthotics.
Kusari A; Borok J; Han AM; Valderrama AJ; Friedlander SF
Pediatr Dermatol; 2018 Jul; 35(4):e206-e209. PubMed ID: 29766555
[TBL] [Abstract][Full Text] [Related]
13. Perforating folliculitis-like reaction related to sorafenib.
Eberst E; Rigau V; Pageaux GP; Guillot B; Kluger N
Cutis; 2014 Jan; 93(1):E8-10. PubMed ID: 24505595
[No Abstract] [Full Text] [Related]
14. Exacerbation of psoriasis vulgaris by sorafenib treatment for hepatocellular carcinoma.
Adachi T; Hiraoka A; Okazaki H; Nagamatsu K; Izumoto H; Yoshino T; Tsuruta M; Aibiki T; Okudaira T; Yamago H; Iwasaki R; Suga Y; Mori K; Miyata H; Tsubouchi E; Ninomiya T; Michitaka K
Clin J Gastroenterol; 2020 Oct; 13(5):891-895. PubMed ID: 32468502
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib (NEXAVAR) and differentiated thyroid cancer. Toxic, and no proof of improved survival.
Prescrire Int; 2016 Feb; 25(168):37. PubMed ID: 27042725
[TBL] [Abstract][Full Text] [Related]
16. Grade III hand-foot skin reaction induced by sorafenib.
Chiriac A; Coros MF; Podoleanu C; Stolnicu S
An Bras Dermatol; 2017; 92(4):590-591. PubMed ID: 28954127
[No Abstract] [Full Text] [Related]
17. Sorafenib-induced hand-foot syndrome in a patient of renal cell carcinoma.
Sil A; Das NK
Indian J Pharmacol; 2014; 46(3):334-6. PubMed ID: 24987183
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic atrophy from sorafenib.
Sullivan S
N Engl J Med; 2014 Jan; 370(2):186. PubMed ID: 24401074
[No Abstract] [Full Text] [Related]
19. Pancreatic atrophy from sorafenib.
Hescot S; Vignaux O; Goldwasser F
N Engl J Med; 2014 Jan; 370(2):186. PubMed ID: 24401073
[No Abstract] [Full Text] [Related]
20. Multiple squamous cell carcinomas following treatment with sorafenib for renal cell carcinoma.
El Tal AK; Remichofsky CJ; Mehregan DA; Ganger LK
Int J Dermatol; 2013 Dec; 52(12):1538-41. PubMed ID: 23676092
[No Abstract] [Full Text] [Related]
[Next] [New Search]
